Metastatic lesions of the eye organs in prostate cancer. A systematic review and meta-analysis according to the PRISMA protocol 2020

Cover Page

Cite item

Full Text

Abstract

Aim. To perform systematic review of the literature published in 2000–2024 and meta-analysis of the data according to the PRISMA protocol 2020.

Materials and methods. Data on clinical cases of 60 patients with prostate cancer metastases to ocular structures (orbit or eye) reported from 2000 to 2024 were analyzed. The resulting cohort is the largest on this topic in the last two decades.

Results. Prostate cancer metastases most frequently involved the orbit (including the optic nerve) and choroid; involvement of the iris or ciliary body was rare. In 17 % of patients, ocular symptoms were the first manifestation leading to a prostate cancer diagnosis. The optimal treatment approach was a combination of systemic prostate cancer therapy (androgen deprivation ± chemotherapy) with local ocular radiotherapy. Hormone therapy played a key role in prolonging survival and improving quality of life, whereas orbital radiation was effective for palliating symptoms and partially restoring vision. The median survival after detection of ocular metastases was approximately 6–12 months.

Conclusion. Ocular metastases of prostate cancer are an extremely rare but clinically significant condition. Timely diagnosis and combined systemic and local treatment may improve the prognosis and quality of life of such patients despite an overall poor outcome.

Limitations. The retrospective and heterogeneous nature of available data, small sample size (60 cases), and potential publication bias limit the generalizability of the results.

About the authors

V. A. Vorobev

Irkutsk State Medical University, Ministry of Health of Russia; Bashkir State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
ORCID iD: 0000-0003-3285-5559
Russian Federation, 1 Krasnogo Vosstaniya St., Irkutsk 664003; 3 Lenina St., Ufa 450008

A. V. Shcherbatykh

Irkutsk State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
Russian Federation, 1 Krasnogo Vosstaniya St., Irkutsk 664003

A. A. Izmailov

Bashkir State Medical University, Ministry of Health of Russia; Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan, Ufa

Email: chap343@yandex.ru
ORCID iD: 0000-0002-8461-9243
Russian Federation, 3 Lenina St., Ufa 450008; 73/1 Oktyabrya Prospekt, Ufa 450054

Andrey B. Chaprak

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan, Ufa

Author for correspondence.
Email: chap343@yandex.ru
ORCID iD: 0009-0008-3906-6521
Russian Federation, 73/1 Oktyabrya Prospekt, Ufa 450054

A. R. Farganov

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan, Ufa

Email: chap343@yandex.ru
ORCID iD: 0009-0005-4019-9602
Russian Federation, 73/1 Oktyabrya Prospekt, Ufa 450054

A. R. Khaziev

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan, Ufa

Email: chap343@yandex.ru
ORCID iD: 0000-0001-9142-480X
Russian Federation, 73/1 Oktyabrya Prospekt, Ufa 450054

A. I. Garifullin

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan, Ufa

Email: chap343@yandex.ru
ORCID iD: 0000-0002-7616-3899
Russian Federation, 73/1 Oktyabrya Prospekt, Ufa 450054

K. M. Su-Yanz

Irkutsk State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
ORCID iD: 0009-0005-9143-916X
Russian Federation, 1 Krasnogo Vosstaniya St., Irkutsk 664003

A. I. Syrova

Irkutsk State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
ORCID iD: 0009-0003-0616-3257
Russian Federation, 1 Krasnogo Vosstaniya St., Irkutsk 664003

A. I. Syrova

Irkutsk State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
ORCID iD: 0009-0001-9400-1738
Russian Federation, 1 Krasnogo Vosstaniya St., Irkutsk 664003

V. N. Pavlov

Bashkir State Medical University, Ministry of Health of Russia

Email: chap343@yandex.ru
ORCID iD: 0000-0003-2125-4897
Russian Federation, 3 Lenina St., Ufa 450008

References

  1. Sekhoacha M., Riet K., Motloung P. et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules 2022;27:5730. doi: 10.3390/molecules27175730
  2. Kelkar N., Findakly D., Wang J. Metastatic prostate cancer to the optic canal: a large-cohort analysis. Cureus 2023;15:e46598. doi: 10.7759/cureus.46598
  3. Shields C.L., Shields J.A., Gross N.E. et al. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104(8):1265–76. doi: 10.1016/S0161-6420(97)30148-1
  4. Oladeji A.A., Jatto J., Ntekim A.I., Edijana B.O. Prostate cancer with orbital metastasis: a case series. J Med Case Rep Case Ser 2024. doi: 10.38207/JMCRCS/2024/SEP051104109
  5. Matsuo T., Tanaka T., Nakamura A., Wada K. Prostate cancer detected by choroidal tumor and complete response to hormonal therapy: case report and literature review of 24 patients with choroidal metastasis from prostate cancer. J Investig Med High Impact Case Rep 2021;9:23247096211026471. doi: 10.1177/23247096211026471
  6. Palmisciano P., Ferini G., Ogasawara C. et al. Orbital metastases: a systematic review of clinical characteristics, management strategies, and treatment outcomes. Cancers (Basel) 2021;14:94. doi: 10.3390/cancers14010094
  7. Boldt H.C., Nerad J.A. Orbital metastases from prostate carcinoma. Arch Ophthalmol 1988;106(10):1403–8. doi: 10.1001/archopht.1988.01060140567024
  8. De Potter P., Shields C.L., Shields J.A., Tardio D.J. Uveal metastasis from prostate carcinoma. Cancer 1993;71(9):2791–6. doi: 10.1002/1097-0142(19930501)71:9<2791::AID-CNCR2820710917 >3.0.CO;2-Y
  9. Shreffler J., Huecker M.R. Hypothesis testing, p values, confidence intervals, and significance. StatPearls. Treasure Island (FL): StatPearls Publishing, 2025.
  10. Vrbin C.M. Parametric or nonparametric statistical tests: considerations when choosing the most appropriate option for your data. Cytopathology 2022;33(8):663–7. doi: 10.1111/cyt.13174
  11. Gopishetty S., Singh L., Aqil M. et al. Prostate cancer with orbital metastasis. Cureus 2025;17(3):e80727. doi: 10.7759/cureus.80727
  12. Pezzulla D., Di Franco R., Zamagni A. et al. Radiotherapy of orbital metastases: a systematic review of management and treatment outcomes on behalf of Palliative Care Study Group of Italian Association of Radiotherapy and Clinical Oncology (AIRO). Br J Radiol 2023;96(1151):20230124. doi: 10.1259/bjr.20230124
  13. Gerba-Górecka K., Romanowska-Dixon B., Karska-Basta I. Clinical characteristics and management of ocular metastases. Cancers (Basel) 2025;17:1041. doi: 10.3390/cancers17061041
  14. Chik J.Y.K., Leung C.W.L., Wong K.H. Palliative radiation therapy for patients with orbital and ocular metastases. Ann Palliat Med 2020;9(6):4458–66. doi: 10.21037/apm.2019.12.02
  15. Lundberg S., Lee S.-I. A unified approach to interpreting model predictions. arXiv 2017. doi: 10.48550/arXiv.1705.07874
  16. Shields J.A., Shields C.L., Eagle H. et al. Fine-needle aspiration biopsy of suspected intraocular tumors: the 1992 Urwick Lecture. Ophthalmology 1993;100(12):1677–84. doi: 10.1016/S0161-6420(93)31418-1
  17. Nabih O., Mtalai N., El Maaloum L. et al. Orbital metastases from prostate adenocarcinoma: case report and review of the literature. Ann Med Surg (Lond) 2022;76:103530. doi: 10.1016/j.amsu.2022.103530
  18. Ermoian R.P., Kalina R.E., Yu E.Y., Parvathaneni U. Ocular prostate cancer metastasis treated with external beam radiation. Retin Cases Brief Rep 2011;5(4):306–8. doi: 10.1097/ICB.0b013e3181f66ad2
  19. Tun K., Bulut T. Triple orbital metastases from prostate cancer. Neurol Neurochir Pol 2016;50(5):392–4. doi: 10.1016/j.pjnns.2016.06.007
  20. Solnik M., Paduszyńska N., Czarnecka A.M. et al. Imaging of uveal melanoma – current standard and methods in development. Cancers (Basel) 2022;14:3147. doi: 10.3390/cancers14133147.
  21. Albert D.M., Rubenstein R.A., Scheie H.G. Tumor metastasis to the eye. II. Clinical study in infants and children. Am J Ophthalmol 1967;63(4):727–32. doi: 10.1016/0002-9394(67)91298-6

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 Vorobev V.A., Shcherbatykh A.V., Izmailov A.A., Chaprak A.B., Farganov A.R., Khaziev A.R., Garifullin A.I., Su-Yanz K.M., Syrova A.I., Syrova A.I., Pavlov V.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.